Certified by Founder Lodge
Alamar Biosciences, Inc.
United States - Fremont, California
START UP
1 Disclosed Funding Rounds $128,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 27 ,2024 | Series C | $128,000,000 |
Sands Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Antithesis | $105,000,000 | (Dec 3, 2025)
minitap | $4,100,000 | (Dec 3, 2025)
HotHouse Therapeutics | $3,835,279 | (Dec 3, 2025)
Soxton.AI | $2,500,000 | (Dec 3, 2025)
Reema Health | $19,000,000 | (Dec 3, 2025)
